Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2004
07/15/2004US20040138441 Novel gene functionally related to dyslexia
07/15/2004US20040138420 Fluorescent proteins
07/15/2004US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders
07/15/2004US20040138414 Secreted proteins
07/15/2004US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor
07/15/2004US20040138161 Methods of modulating proliferative conditions
07/15/2004US20040137622 Modular transfection systems
07/15/2004US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same
07/15/2004US20040137611 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response
07/15/2004US20040137608 comprises multiple wells in a solid support and a plurality of likers attached to the wells; solid phase synthesis; chemical libraries; for drug screening
07/15/2004US20040137598 Peptidylarginine deiminase 6
07/15/2004US20040137597 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
07/15/2004US20040137595 Mfq-111, a novel human gtpase like protein
07/15/2004US20040137593 Regulation of human serine/threonine protein kinase-like protein
07/15/2004US20040137592 Comprises phosphatidyl inositol kinase related protein for use in the identification of modulators for treatment of cystic fibrosis and/or muscular disorders
07/15/2004US20040137589 Human myosin-like polypeptide expressed predominantly in heart and muscle
07/15/2004US20040137572 Compositions and methods for generating conditional knockouts
07/15/2004US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis
07/15/2004US20040137553 Enzymic microassay for measurement of chlorite, chlorate and perchlorate
07/15/2004US20040137552 kits for quantitative determination of differential protein expression and/or modification in different samples; solid phase synthesis
07/15/2004US20040137551 Cervical acid phosphatase - papanicolaou (CAP-PAP) test kit, method and accesories, processes for producing and using the same
07/15/2004US20040137550 Acetylcholinesterase assay
07/15/2004US20040137549 Diagnostic and examination method for cancer of the colon using tannase as indication
07/15/2004US20040137548 for drug screening microbiocides; acyl carrier protein mixtures; enzyme inhibitors
07/15/2004US20040137546 Method for determination of free and combined glycerin in biodiesel
07/15/2004US20040137545 Luminous bacteria and methods for the isolation, identification and quantitation of toxicants
07/15/2004US20040137540 by calculating the ratio of the amount of survivin and the amount of pro-apoptosis factor (PAF) in a physiological sample; kits
07/15/2004US20040137531 Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases
07/15/2004US20040137530 for diagnostic assays/genetically engineering drugs and vaccines
07/15/2004US20040137529 Identifying prions in infectious conformations in mammalian nervous system tissue; diagnosing spongiform encephalopathies in animals
07/15/2004US20040137527 Method for producing a layer of functional molecules
07/15/2004US20040137522 Genes and proteins altering Tau-related neurodegeneration
07/15/2004US20040137517 for G-protein coupled receptor (GPCR) competitive inhibitor drugs; utilizing fatty acids
07/15/2004US20040137516 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
07/15/2004US20040137511 Method for detecting a mycobacterium tuberculosis specific intein and use in diagnosis of tuberculosis
07/15/2004US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits
07/15/2004US20040137507 Method for separating cells
07/15/2004US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells
07/15/2004US20040137504 using the polymerase chain reaction to determine in one reaction the alleles of each locus contained within the multiplex system; high throughput assay; kits
07/15/2004US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs
07/15/2004US20040137498 Parallel genotyping of multiple patient samples
07/15/2004US20040137497 using a first primer that hybridizes to the target polynucleotide, hybridizing the equal length extension products to a second primer, producing extension products from the second primer, and detecting the extension products; solid phase synthesis
07/15/2004US20040137495 Meg-4 protein
07/15/2004US20040137494 using expressed sequence tags (ESTs); open reading frames; genetic engineering; kits
07/15/2004US20040137493 Methods and compositions for amplifying detectable signals in specific binding assays
07/15/2004US20040137489 through comparative global WNT gene signaling antagonist expression profiling (soluble frizzled related protein 3 (SFRP-3/FRZB) or human homologue of Dickkopf-1 (DKK1)); gene expression inhibition
07/15/2004US20040137488 Methods for identifying the activity of gene products
07/15/2004US20040137486 correlates known sensory, physical, ingredient, or processing properties (color, taste, texture, pH, moisture content) with a spectrum of target species of microorganisms that are present
07/15/2004US20040137484 Nucleic acid amplification methods
07/15/2004US20040137480 comprises a fusion protein comprising a beta-galactosidase enzyme donor oligopeptide fused to a surrogate protein; gene expression inhibition; for diagnosis/therapy; kits
07/15/2004US20040137479 Compositions and methods for visual ribonuclease detection assays
07/15/2004US20040137478 that use whispering gallery modes (WGMs) by having receptors selectively substantially provided at only an equator region, formed of a relative high infrared material, and/or having a relatively small radius
07/15/2004US20040137477 A3AR as a marker for a diseased state
07/15/2004US20040137476 Method of detection of SP-A2 gene variants useful for prediction of predisposition to aspergillosis
07/15/2004US20040137475 nucleic acid or a poly(amino acid) samples and dyes in form of staining solution are combined for sufficient time to form dye-analyte complex and are illuminated with an appropriate wavelength whereby nucleic acid or a poly(amino acid) is detected
07/15/2004US20040137474 by comparing gene patterns for breast cancer; for early diagnosis; kits
07/15/2004US20040137473 Use of representations of DNA for genetic analysis
07/15/2004US20040137472 identifying a compound capable of modulating a splicing event in a pre-mRNA molecule using a cDNA incapable of gene expression in the absence of modulation of a splicing event; using compound(s) identified to treat genetic disorders
07/15/2004US20040137470 determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at said locus which indicates the presence or absence of a chromosomal abnormality; non-invasive method for fetal DNA testing
07/15/2004US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker
07/15/2004US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity
07/15/2004US20040137466 utilizing conserved regions of greater than or equal to 4 amino acids in length for use in isolating/identifying gene orthologs from different plant families
07/15/2004US20040137464 Parallel analysis of single nucleotide polymorphisms
07/15/2004US20040137463 Method of identifying target organisms by determining the characteristics of their intronic region nucleic acids
07/15/2004US20040137462 internal calibration standard which allows more accurate comparison of data between arrays; detecting hybridization patterns of said test and control sets of target nucleic acids to said array(s)
07/15/2004US20040137461 Molecular detection systems utilizing reiterative oligonucleotide synthesis
07/15/2004US20040137460 ES cells (embryonic stem cells); ECAT gene (ES cell associated transcript gene) marker to determine if the cell is an ES cell; genetic probes; use to select human stem cells or mouse stem cells
07/15/2004US20040137458 nucleic acid molecular tags; molecular beacons; wherein the nucleic acid sequences of primer binding sequences, the marker and the spacer are chosen so as to minimize or prevent secondary structure formation; use in quality control analysis
07/15/2004US20040137456 Method for identifying and characterizing individual dna molecules
07/15/2004US20040137454 Plasmid for determining cellular polyamine levels comprising DNA construct containing luciferase gene and SV40 promoter; transfection into cultured mammalian cells stimulates translational frameshifting
07/15/2004US20040137452 Diagnostic test
07/15/2004US20040137451 Method of detecting nucleotide polymorphism
07/15/2004US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2
07/15/2004US20040137449 Magnetic isolation and purification of nucleic acids
07/15/2004US20040137448 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosis and treatment of cell proliferative, neurological, developmental, and autoimmune/inflammatory disorders
07/15/2004US20040137447 Human sphingosine-1-phosphate phosphatase
07/15/2004US20040137446 Fab I and inhibition of apicomplexan parasites
07/15/2004US20040137445 Microchip liquid chromatography; injections are made by electro-osmotically pumping sample through the injection channel that crosses the separation channel, followed by a switching of the potentials to force a plug into the separation channel
07/15/2004US20040137444 Method for detecting abnormal gene
07/15/2004US20040137442 Amplified and overexpressed gene in colorectal cancers
07/15/2004US20040137440 Of given nucleotide sequence; use in diagnosing or predicting susceptibility to prostate cancer by contacting with specimen (blood, urine, tissue) and determining the expression level
07/15/2004US20040137439 Nucleic acid amplification
07/15/2004US20040137436 Method for measuring drug resistance
07/15/2004US20040137435 Human abc transporter expressed in liver,atil
07/15/2004US20040137431 Exposing sample to an oligomer comprising a parallel-stranded hairpin and allowing it to hybridize with the RNA; nucleic acid probes; use in gene therapy drugs
07/15/2004US20040137430 Contacting sample with bacteriophage comprising a binding agent (biotin) , incubating and allowing complex to form; substrate comprising immobilized ligand (streptavidin)
07/15/2004US20040137429 Of given nucleotide sequence; Complexed with a toxin moiety; Use in treating human immunodeficiency virus (HIV)
07/15/2004US20040137428 Contacting the sample with a plurality of ligands such as oligosaccharide, siderophore, aferrisiderophore, and a vitamin; detecting binding to the surface of the solid suppot; iron-chelating agent
07/15/2004US20040137427 Retentate chromatography and protein chip arrays with applications in biology and medicine
07/15/2004US20040137426 Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells
07/15/2004US20040137424 Expression cassette comprising a promoter sequence which enables transcription of a minus strand RNA; Hepatitis C
07/15/2004US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay
07/15/2004US20040137420 Irradiating a laser to a intracellular region and analyzing the mass ions; determining the chemical structure by correlating with molecular weight; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
07/15/2004US20040137141 Solution drying system
07/15/2004US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
07/15/2004US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response
07/15/2004US20040137005 Chlamydia protein, sequence and uses thereof
07/15/2004US20040136999 Melanoma antigens and methods of use
07/15/2004US20040136993 inducing an immunogenic response against alpha-SN
07/15/2004US20040136972 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues